跳至主要内容
临床试验/NCT03860350
NCT03860350已完成不适用

Aged Garlic Extract (Kyolic) Study at Lund University, Sweden

Lund University Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Change in coronary artery calcium (CAC) score

研究概览

简要总结

The primary intention of the study is to examine the effect of aged garlic extract (AGE) on the absolute change in coronary artery calcium (CAC). The second intention is to examine the effect of AGE on inflammatory biomarkers and microcirculation. It is a double blind placebo controlled study. The participants will ingest AGE during a period of one year. The CAC will be controlled by computer tomography (CT) scan; the inflammatory biomarkers through blood sample test and the microcirculation through laser speckel imagining and laser doppler before and after the one year period of AGE ingestion.

详细描述

Objectives:

Effect on coronary artery atherosclerosis / the progression of atherosclerosis Effect on inflammatory and oxidation biomarkers Cholesterol lowering effect Effect on microcirculation

Type of study:

Randomized double blind controlled trial

Number of patients: 80 patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CAC score >10
  • Framingham risk score (10 % or above)
  • Subjects are required to be on stable concomitant medications for at least 12 weeks prior to randomization
  • Subjects with diabetic must have HbA1C < 8.0, and stable HbA1C level variation range within 0.5% for three months.

排除标准

  • Hypersensitivity to AGE therapy,
  • Unstable medical, psychiatric, or substance abuse disorder that may interfere with continuation in the study,
  • Weight ≥325 pounds,
  • Bleeding disorder,
  • History of myocardial infarction,
  • Life-threatening arrhythmia within prior 6 months,
  • Resting hypotension (systolic < 90 mmHg) or hypertension (resting blood pressure >170/110)
  • Heart failure NYHA class III or IV,
  • History of malignancy within the last 5 years (other than skin cancer) or evidence of active cancer which would require concomitant cancer chemotherapy
  • Serum creatinine >1.4 mg/dl
  • Triglycerides > 400 at baseline visit
  • Diabetic subjects with HbA1C > 8 %,
  • Drug or alcohol abuse
  • Conditions interfering with accurate assessment of coronary calcification (metal clips, bypass patients, intracoronary stents) and drug absorption (partial ileal bypass or malabsorption syndrome).
  • Current use of anticoagulants (except for antiplatelet agents)
  • Chronic renal failure
  • Liver failure
  • Hematological or biochemical values at baseline visit outside the reference ranges considered as clinically significant.

研究组 & 干预措施

Placebo

Placebo Comparator

The participants will ingest 600 mg of placebo in two capsules two times a day i.e. 1200 mg/day during a period of one year.

干预措施: Placebo (Dietary Supplement)

Aged Garlic Extract

Active Comparator

The participants will ingest 600 mg of Aged Garlic Extract in two capsules two times a day i.e. 1200 mg/day during a period of one year.

干预措施: Aged Garlic Extract (Dietary Supplement)

结局指标

主要结局

Change in coronary artery calcium (CAC) score

时间窗: One year

CAC is to be defined as a plaque of at least three contiguous pixels (area 1.02 mm 2) with a density of \> 130 Hounsfield units. The lesion score are to be calculated by multiplying the lesion area by a density factor derived from the maximal Hounsfield unit within this area, as described by Agatston S, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832. CAC score is measured at baseline and after one year follow-up and the difference is calculated.

次要结局

  • The changes in the microcirculation measured by Laser Doppler velocimetry(One Year)
  • Changes in Low Density Lipoprotein(One Year)
  • Changes in Triglycerides(One Year)
  • Changes in High Density Lipoprotein(One Year)
  • Changes in BMI(One Year)
  • The changes in Interleukin-6 (IL-6)(One Year)
  • Changes in lipid profile(One Year)
  • Changes in blood sugar(One Year)
  • Changes in Cholesterol(One Year)
  • Changes in Blood pressure(One Year)
  • The changes in inflammatory biomarkers.(One Year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sandra Lindstedt Ingemansson

Senior Consultant and Associate Professor

Lund University Hospital

研究点 (2)

Loading locations...

相似试验

Aged Garlic Extract Study | 临床试验